The cellular therapy landscape continues to evolve beyond hematologic malignancies, now making significant progress in solid ...
Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive ...
Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of ...
Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...
Detectives allege that Martin incited the family's rottweiler to attack Jamaria, who was found with cuts, bruises, and other ...
Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
ShineOn’s proprietary product, SOB100, a HLA-G targeted exosome drug delivery carrier, has passed the U.S. FDA IND review and ongoing Phase I study, making it as a first-in-class–potential HLA-G ...
Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...
The OnePlus 15R is sitting in a pretty interesting place, especially in the US market. It is the OnePlus "cheaper" flagship ...
Claudio Neves Valente, the suspect in the Brown University mass shooting, was found dead tonight after taking his own life, Providence Chief of Police Oscar L. Perez, Jr. said. Follow for live news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback